Three Indian pharmaceutical companies have launched generic versions of semaglutide injections, after the drug’s patent expired, offering lowercost options for patients managing Type 2 diabetes and obesity.

https://www.ndtv.com/health/indian-pharma-giants-launch-low-cost-generic-semaglutide-injections-for-diabetes-weight-management-11246898

AND

India’s Booming Pharma Industry: A Global Game Changer

https://www.devdiscourse.com/article/business/3845915-indias-booming-pharma-industry-a-global-game-changer